Location History:
- Madison, CT (US) (2004 - 2005)
- Deep River, CT (US) (2010)
Company Filing History:
Years Active: 2004-2010
Title: The Innovative Contributions of Robert Ohliger
Introduction
Robert Ohliger, an accomplished inventor based in Madison, CT (US), has made significant contributions in the field of pharmaceutical innovations. With a total of three patents to his name, he has focused on developing compounds that hold promise for various medical applications. His work is particularly relevant in the treatment of disorders linked to receptor activation.
Latest Patents
Robert Ohliger’s latest patents include innovative compounds such as dipiperazinyl ketones and substituted tetrahydroisoquinolines. The patent for dipiperazinyl ketones outlines methods for their preparation and usage, specifically for modulating ligand binding to histamine H3 receptors. These compounds can be utilized in both human and animal treatments, enhancing the potential for therapeutic interventions. In addition, his work on substituted tetrahydroisoquinolines provides ligands that modulate C5a receptor activity, targeting conditions related to pathological C5a receptor activation.
Career Highlights
Ohliger currently works at Neurogen Corporation, a company that specializes in the development of innovative therapeutics. His research is central to enhancing our understanding of receptor modulation and its application in medicine. His expertise and inventiveness in pharmaceutical chemistry have allowed him to contribute valuable insights into drug development.
Collaborations
Throughout his career, Robert Ohliger has collaborated with notable colleagues, including Kyungae Lee and Scott A Mitchell. These partnerships have amplified the impact of his research, as such collaborations often lead to groundbreaking discoveries in the pharmaceutical field.
Conclusion
In summary, Robert Ohliger’s work exemplifies the essence of innovation within the realm of pharmaceuticals. With several patents to his name, he continues to advance the understanding of receptor modulators and their therapeutic applications. His collaboration with fellow researchers further enhances the potential of his work, making him a significant figure in the scientific community.